Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05402579Completed

Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk

Role: collaborator

NCT06004739Not ApplicableRecruiting

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

Role: collaborator

NCT02993341Phase 3Completed

Topical Tranexamic Acid (TXA) in Hip Fractures

Role: lead

NCT00465387Not ApplicableCompleted

FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study

Role: collaborator

NCT00332982Not ApplicableCompleted

Ontario ICU Clinical Best Practices Demonstration Project

Role: collaborator

All 5 trials loaded